---
schema_version: "secwatch.filing_event.v1"
accession: "0001013762-25-001736"
form_type: "8-K"
ticker: "RFL"
cik: "0001713863"
company_name: "Rafael Holdings, Inc."
filed_at: "2025-03-25T23:59:59+00:00"
generated_at: "2026-05-24T05:52:58.513389+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Rafael Holdings stockholders approve share issuance for Cyclo Therapeutics merger

## Summary
- Share issuance proposal passed with 3,706,261 votes For (99.92%) vs. 1,571 Against.
- Adjournment proposal also approved with 3,676,323 For (99.77%) and 32,783 Against.
- Special meeting held March 20, 2025; both proposals were stockholder votes required to proceed with merger.
- Transaction involves exchange of Rafael Class B common stock for Cyclo common stock under August 2024 merger agreement.

## SEC filing metadata
- accession: 0001013762-25-001736
- form_type: 8-K
- ticker: RFL
- cik: 0001713863
- company_name: Rafael Holdings, Inc.
- filed_at: 2025-03-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1713863/000101376225001736/0001013762-25-001736-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1713863/000101376225001736/ea0235330-8k_rafael.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001013762-25-001736
- JSON: https://secwatch.observer/filing/0001013762-25-001736.json
- Plain text: https://secwatch.observer/filing/0001013762-25-001736.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.